ARCHIVES

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

This article is from The Cancer Letter archive.

Vol. 17 No. 01 | January 4, 1991

Download PDF Visit The Full Archive

Related Articles

NCI “Leadership Vacuum” Deepened?

December 22, 1994

American Health Fdn. Honors NCI On Act’s 20th Anniversary

December 13, 1991

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

NCI Budget: How Did NCI Spend Last Year’s Increase? Klausner Lists Activities

November 19, 1999

Large, Conclusive Trials Provide Answers To Treatment Questions For GI Cancers

June 26, 2009

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995